ENLV
NASDAQ

Enlivex Therapeutics Ltd

Overview
ENLV
Symbol
NASDAQ
Exchange
About stock

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Address: 14 Einstein Street, Ness Ziona, Israel, 7403618

Enlivex Therapeutics Ltd dividend calculator
Report issue